DR. DANIEL BERGER, M.D.
Osteopathic Medicine at Congress Pkwy, Chicago, IL

Product Management Team Lead at Bretford

Furniture

Bretford since May 2012 - Product Management Team Lead Bretford Nov 2011 - Apr 2012 - Product Manager Little Sisters of the Poor May 2011 - Oct 2011 - Assistant Development Director Chicago History Museum Jan 2006 - Sep 2011 - Volunteer Tour Guide Little Sisters of the Poor Jul 2009 - May 2011 - Development Assistant & Resident Accounts Coordinator Museum of Broadcast Communications Apr 2009 - Aug 2009 - Co-Editor of "Chicago Television" Museum of Broadcast Communications Aug 2005 - Apr 2009 - Archives Director University of Kansas - Natural History Museum Aug 2004 - May 2005 - Curatorial Assistant Spencer Museum of Art Sep 2003 - Dec 2004 - Rights & Reproductions Assistant

University of Kansas 2003 - 2005
M.A., Museum Studies University of Illinois at Urbana-Champaign 1994 - 1998
B.A., History

Event Planning

Internal Medicine

Hiv Positive

Distinguished Researcher in HIV Medicine, Serono Laboratories, May 2000, Charles E. Clifton Leadership Award: Test Positive Aware Network "For Excellence & Leadership to the Chicago HIV Community", 2006, Preceptor Award, Recognition of Outstanding Teaching in Internal Medicine, American College of Physicians, April 2006, TIITAN: A Randomized, Controlled Phase III Trial Compariing 48-week Efficacy and Safety of Darunavir/Ritonavir (DRV/r) with Lopinavir/Ritonavir (LPV/r) in treatment experienced patients., 2007, Effects of TH9507, a Growth Hormone Releasing Factor (GRF) Analog, on HIV-associated abdominal fat accumulation: A Multicenter, Double-blind Placebo-controlled Trial with 412 Randomized Patients., Feb. 2007, Week 24 Efficacy and Safety of TMC114/ritonavir in treatment-experienced HIV Patients., 2007, Comparison of 48 week efficacy and safety of darunavir/ritonavir (DRV/r) with lopinavir/ritonavir (LPV/r) in LPV/r-naïve, treatment experienced, patients: a randomized, controlled phase III trial (TIITAN)., July 2007, Once-daily abacavir/lamivudine (ABC/3TC) and boosted Atazanavir (ATV/RTV) in antiretroviral-naïve HIV-1 infected subjects: 48-week results from COL102060 (SHARE);, July 2007, The HIV integrase inhibitor GS-9137 has potent antiretroviral activity in treatment-experienced patients [Abstract 143LB], 2007, Efficacy and Safety of TMC125 in Patients with Highly Resistant HIV-1: Primary 24-week Analysis of trial TMC125-C223., Mar 2007

English, Spanish

Dr. Daniel S. Berger offers Chicago our new state-of-the-art medical and research center, as we continue to provide our well-known brand of individualized HIV and Primary care.

Compliance Analyst at Fireman's Fund Insurance Company

Insurance

Fireman's Fund Insurance Company - Greater Chicago Area since Jan 2013 - Compliance Analyst RLI - Peoria, Illinois Area Sep 2010 - Dec 2012 - Compliance Analyst COUNTRY ® Financial - Bloomington/Normal, Illinois Area Jan 2009 - Dec 2009 - Compliance Intern City of Champaign - champaign Illinois May 2007 - Aug 2008 - Finance Intern

Illinois State University 2008 - 2010
B.S., Finance Illinois State University 2008 - 2010
Bachelor of Science (BS), Finance, Insurance

Insurance, Underwriting, Financial Analysis, Property & Casualty Insurance, Microsoft Excel, PowerPoint, Financial Risk, Microsoft Office, Risk Management, Microsoft Word, Data Analysis, Outlook, Customer Service, Access, Leadership

Medical Practice

Takeda Pharmaceuticals Jun 2010 - Sep 2010 - Cardiometabolic Clinical Sciences & Strategies Intern Chicago Heart Institute 2007 - 2007 - Clinical Research Assistant Coordinator/Medical Assistant

Chicago Medical School at Rosalind Franklin U-Med & Science 2009 - 2013
University of Illinois at Urbana-Champaign 2005 - 2009
Bachelor of Science, Molecular and Cellular Biology Deerfield High School 2001 - 2005

Clinical Research

Medical Practice

Consumer Goods

Internist

2835 N Sheffield Ave, Chicago, IL 60657

Internist

1653 W Congress Pkwy, Chicago, IL 60612